Sorted By:


New surveys find payers and providers want more data from biopharmaceutical companies

PhRMA  |  Blog Post

View the survey findings here.

Examining the brain in The New Era of Medicine

PhRMA  |  Blog Post

This discussion will be live-streamed here beginning at 8:30 a.m.

New report shows better diabetes management saves money and improves patient outcomes

PhRMA  |  Blog Post

Learn more about the benefits of better diabetes’ treatment by reading IHS Markit’s study here.

Celebrating tremendous advances in HIV/AIDS on National Youth HIV/AIDS Awareness Day

PhRMA  |  Blog Post

New treatments alleviating common side effects of the disease have also become available allowing for better disease management.

PhRMA Board of Directors Elects New Officers, Welcomes New Member Company

PhRMA  |  Press Release

“Helping patients and addressing the burden of disease is what drives the men and women of this industry every single day,” said Bradway.

Higher deductibles and more dissatisfaction with health plans according to new poll

PhRMA  |  Blog Post

[1] A small share (12 percent) of those surveyed is in grandfathered plans that do not have to meet new Affordable Care Act requirements.

Yep, Obamacare Costs a Fortune

Access Better Coverage  |  From Our Network

More important, and potentially worrisome for the law's defenders: Average deductibles for silver plans (the most popular type of exchange coverage) are about three times as high as on employer plans.

#RarePOV Conversation Generates Strong Enthusiasm for Rare Disease Day on February 28th

PhRMA  |  Blog Post

You can find information on events in other countries on the global Rare Disease Day website.

New Questions About Why More Women Than Men Have Alzheimer's

From Hope To Cures  |  From Our Network

But it wasn't until after her own diagnosis a few years ago that Shives looked up the gender statistics.

New Report: Many Exchange Plans Burden the Most Vulnerable Patients with High Out-of-Pocket Costs for Vital Medicines; Patients left with limited access

PhRMA  |  Press Release

Eric Hargis, Colon Cancer Alliance CEO, stated, “Colorectal cancer is the second leading cause of cancer deaths in America; however, thanks to the development of personalized therapies and other innovative treatments the prognosis for colorectal cancer patients is the best it has ever been and today there are more than one million survivors in the United States.

Ads: Let's Talk About Cost

PhRMA  |  From PhRMA

Discussions about costs are important. No patient should have to worry about whether they can afford the care they need. At the same time, it is important to look at costs across the health care system and not just the share going toward life changing medicines. Explore our ads below to l...

World Anti-Counterfeiting Day Puts Spotlight On Growing Foreign Counterfeit Medicine Threat

PhRMA  |  Press Release

PhRMA members alone invested an estimated $49.5 billion in 2011 in discovering and developing new medicines.

World AIDS Day: Making progress

PhRMA  |  Blog Post

On average, it costs $2.6 billion and takes between 10 to 15 years to bring a new medicine to patients.

A Sea Change in Treating Heart Attacks

From Hope To Cures  |  From Our Network

At Yale-New Haven Hospital, where half the patients used to have to wait at least 150 minutes before their arteries were opened, the median time is now 57 minutes.

Burden on patients: Insurance benefit design’s impact on patient access to medicines

PhRMA  |  Blog Post

Asthma and COPD: Utilization management for these medicines is low compared to other conditions, but remains higher than employer coverage.

World Cancer Day: Revolutionizing Treatment for Patients is “Not Beyond Us”

PhRMA  |  Blog Post

If you’re looking to get involved in World Cancer Day, share this post or the videos and be sure to use the hashtags #WorldCancerDay and #NotBeyondUs to help spread the world about how innovative cancer medicines are enabling people to take back their lives.

PhRMA Convenes Stakeholders to Discuss Value Assessments and New Ways to Pay for Medicines

PhRMA  |  Press Release

Since 2000, PhRMA member companies have invested more than half a trillion dollars in the search for new treatments and cures, including an estimated $58.8 billion in 2015 alone.

Boston Kickoff: The New Era of Medicine

PhRMA  |  Video

The event was the first in a national dialogue series PhRMA is supporting as part of its new GOBOLDLY campaign.

Exploring the new era of medicine

PhRMA  |  Blog Post

To learn more about the positive impact of the work being done by America’s biopharmaceutical companies, visit

A new era in cancer

PhRMA  |  Blog Post

RSVP to hear about the progress being made day after day by leading minds on the front line of this ongoing fight against cancer.

Using setbacks as stepping stones in Alzheimer’s research

PhRMA  |  Blog Post

The Alzheimer’s community is watching these trials closely and the many others taking new approaches to fight this terrible disease.

World Cancer Day: Reflecting on progress and hope for the future in cancer treatment

PhRMA  |  Blog Post

Check out an interview with Marisa Dolled-Filhart, Ph.D., director of pathology and companion diagnostics at Merck, on her work as part of the oncology team.

What they are saying about new hepatitis C cure: “That's actually a great deal”

PhRMA  |  Blog Post

That's actually a great deal.

New Medicines Made Available through PDUFA

PhRMA  |  Graphic

The Prescription Drug User Fee Act (PDUFA) has helped bring more than 1,500 new safe and effective medications to patients.

Let's Talk About Cost

PhRMA  |  From PhRMA

View reports that explore the slowdown in medicine cost growth, the rising cost of chronic disease, insurance coverage of medicine, the role of middlemen, and what our industry can do to make medicine more affordable for patients....

You have reviewed the first 100 results out of 2100. Each page contains 25 results. You're on page 4.

prev 1 2 3 4 5 6 next